Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

CHANTIX 1 MG TABLET

varenicline tartrate
$8.0100per EA
High Outlier

Strength

1 mg/1

Manufacturer

Pfizer Inc.

NDC

00069046956

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/1/2022

Active Ingredients

VARENICLINE TARTRATE

Approval Type

New Drug (NDA)

FDA Application

NDA021928

On Market Since

5/10/2006

Pharmacological Classes

Cholinergic Agonists
Cholinergic Receptor Agonist
Partial Cholinergic Nicotinic Agonist
Partial Cholinergic Nicotinic Agonists

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

+2.7%

All

+130.7%

Generic Alternatives

Save up to 95%

6 alternatives • Same active ingredient

VARENICLINE 1 MG TABLET
Generic
60687064821•American Health Packaging
$0.4111
Save 95%
VARENICLINE 1 MG TABLET
Generic
67877074495•Ascend Laboratories, LLC
$0.4111
Save 95%
VARENICLINE 1 MG TABLET
Generic
43598090856•Dr. Reddy's Laboratories Inc.
$0.4111
Save 95%
VARENICLINE 1 MG TABLET
Generic
49884015676•Endo USA Inc.
$0.4111
Save 95%
VARENICLINE 1 MG CONT MONTH BX
Generic
68462089404•Glenmark Pharmaceuticals Inc., USA
$0.4111
Save 95%
VARENICLINE 1 MG TABLET
Generic
00904741435•Major Pharmaceuticals
$0.4111
Save 95%

Related Drugs

Same classification

EVOXAC 30 MG CAPSULE
Brand
00713088301•Cosette Pharmaceuticals, Inc.
$7.8316
per EA
VUITY 1.25% EYE DROP
Brand
00074709806•AbbVie Inc.
$23.5529
per ML
VUITY 1.25% EYE DROP
Brand
00074709804•AbbVie Inc.
$31.0595
per ML
TYRVAYA 0.03 MG NASAL SPRAY
Brand
73521003002•Oyster Point Pharma, Inc.
$79.5629
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy